A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis - Université de Lorraine Access content directly
Conference Papers Year : 2013

A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis

Dates and versions

hal-01509566 , version 1 (18-04-2017)

Identifiers

Cite

P. Richette, E. Maheu, G. Baron, P. Ravaud, A. Rialland, et al.. A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis. Annual European Congress of Rheumatology EULAR 2013, Jun 2013, Madrid, Spain. ⟨10.1136/annrheumdis-2013-eular.223⟩. ⟨hal-01509566⟩
100 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More